FDA Approved: AMBRISENTAN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves the original ANDA for Ambrisentan from Zydus Lifesciences Limited, providing a generic option for use in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)